Navigation Links
Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011
Date:7/27/2011

PALO ALTO, Calif., July 27, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today is reporting net earnings from continuing operations of $0.83 per diluted share in the third quarter of fiscal year 2011, up 12 percent from $0.74 in the year-ago quarter.  Revenues for the quarter were $649 million, up 12 percent from the prior-year period and up 9 percent on a constant currency basis.  Order backlog at the end of the third quarter rose 10 percent from the prior-year quarter to $2.3 billion.

"Continued healthy demand for newer products contributed to solid growth in net orders and revenues during the third quarter in both our Oncology Systems and X-Ray Products business segments," said Tim Guertin, president and CEO of Varian Medical Systems.  "A variety of factors, including product retrofits in our Oncology business as well as challenging conditions in our Other segment, contributed to lower than normal gross margin for the quarter. Year-to-date, gross margins are up by half a percent."

At the end of the quarter, the company had $568 million in cash and cash equivalents and $18 million of debt.  During the third quarter, the company retired an additional 631,000 shares to complete the previously announced accelerated share repurchase program.  Fully diluted shares outstanding for the quarter were 119.1 million, down 5.4 million from the year-ago quarter.  Days sales outstanding for the quarter was 81, an increase of 1 day from the year-ago period.  

Oncology SystemsThird quarter revenues from Oncology Systems' products and services for radiotherapy, radiosurgery, and brachytherapy totaled $513 million, up 12 percent from the same period last fiscal year.  Third quarter net orders totaled $553 million, up 9 percent versus the year-ago period.  Net orders rose 18 percent in international markets and were even
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... TARRYTOWN, N.Y. and BRIDGEWATER, N.J. ... Inc. (NASDAQ: REGN) and Sanofi US (EURONEXT: SAN and ... heart disease organizations to launch Cholesterol Counts , ... know about cholesterol, their numbers, and the risks associated ... to visit www. CholesterolCounts .com to take ...
(Date:12/15/2014)... 2014   DaVita HealthCare Partners Inc.  (NYSE: ... largest and most innovative health care communities, today ... DaVita Clinical Research  (DCR) and  HealthCare Partners Clinical Research ... extensive clinical research and data analytics services, specifically ... end-stage renal disease (ESRD), as well as primary ...
(Date:12/13/2014)... 2014 Research and ... of the  "Global Catheters Market (Product Types ... Company Profiles, Analysis, Segmentation and Forecast, 2013 ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... medical grade material such as plastic, silicon ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... 29 Zeltiq Aesthetics, a science-based medical device company dedicated ... unwanted fat tissue, has announced the appointment of Gordie ... Mitch Levinson, the founder of Zeltiq Aesthetics, who served as ... a member of the Board of Directors since 2006. ...
... Misonix, Inc. (Nasdaq: MSON ), a developer of ... is used for the ablation of tumors and worldwide ... release fourth quarter and fiscal year ended June 30, ... Michael A. McManus, President and Chief Executive Officer ...
Cached Medicine Technology:Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 3Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern 2
(Date:12/17/2014)... Dr. Myo Nwe is the co-author of a new ... and co-founder of the Ace Medical Weight Loss Center in ... broad look at the industry of weight loss, and how ... film and in television shows, however, she says the topic ... and played for basic laughs, which she believes impacts whether ...
(Date:12/17/2014)... 17, 2014 In its comprehensive analysis ... its Argus Claim Review division have recently identified out-of-network ... common ways savings are achieved on behalf of employer-clients. ... of dollars in savings to Argus each year, with ... As explained by Tom Doney, Cypress president and CEO, ...
(Date:12/17/2014)... Mozes HealthDay Reporter , TUESDAY, ... infectious diseases, one worrisome phenomenon is when an illness that ... -- known as zoonosis -- is not uncommon and keeps ... an animal-borne disease might make inroads into the human population. ... -- and the culprits in this case were guinea pigs. ...
(Date:12/17/2014)... Amy Norton HealthDay Reporter , ... been believed to improve overall health, but a growing body ... heart, a new review finds. In fact, the benefits ... walking, said lead researcher Paula Chu, a doctoral candidate at ... of 37 clinical trials, found that people randomly assigned to ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Main Street ... clinic, is weighing in on a new study providing ... on the oral hygiene of children. , Sufficient enough ... drinks, such as pop or juice drinks, with the ... looming, however, is whether drinks listed as 100% fruit ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
... Paragon Medsystems unveiled their new corporate identity at the ... immediately, the company name will be California MedTech.The name ... turnkey development and manufacturing services to the medical electronics ... on the medtech sector, as well as our ongoing ...
... GA is now offering same day porcelain restorations for their patients. ... care, implants crowns and amazing porcelain veneers. , ... ... to offer same day crowns, fillings, and veneers to qualifying patients. ...
... aggressive form of liver cancer and one of the ... at Virginia Commonwealth University School of Medicine, Richmond, have ... levels in human HCC tumor samples and generates a ... targeting this gene (AEG1), or the protein that it ...
... hard for teens to ignorePHOENIX, Feb. 16 Arizona seeks ... campaign -- "Brought to you by addiction." -- a mass ... addiction for an audience age 12 to 17. Its launch, ... in Arizona that until now focused on the health impacts ...
... Linkage between the two might be genetic, researchers say , , ... history of melanoma are twice as likely to develop Parkinson,s ... this association are not clear, other studies have shown that ... melanoma. , "For people with a family member with melanoma, ...
... family history of melanoma may have a greater risk of ... will be presented at the American Academy of Neurology,s 61st ... , The study involved nearly 157,000 people who did ... or siblings had been diagnosed with melanoma, the deadliest form ...
Cached Medicine News:Health News:Paragon Medsystems Becomes California MedTech 2Health News:Atlanta Dental Spa in Alpharetta, GA Offering CAD / CAM Dentistry 2Health News:Statewide Anti-Smoking Campaign Takes New Approach in Curbing Teen Smoking 2Health News:Statewide Anti-Smoking Campaign Takes New Approach in Curbing Teen Smoking 3Health News:Family History of Melanoma Doubles Parkinson's Risk 2
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte...
... for cholangiography and bile ... Dual lumen catheter design ... imaging and wire basket ... Supplied sterile in peel-open ...
... the MAMMOTOME® HH (Hand Held) ... procedure using ultrasound imaging for ... to locate breast abnormalities, you ... map the area you will ...
... Line Reinforcement Material is a safe, ... air leaks and as such, the ... biocompatible, ePTFE material requires no pretreatment ... load and fire and the material's ...
Medicine Products: